FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.10  |  FHIR Version n/a  User: [n/a]

386898005: névirapine (substance)


Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2003. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
1461076017 Nevirapine (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
1481012015 Nevirapine en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
619591000241115 névirapine (substance) fr Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT Common French translation module (core metadata concept)
827671000172115 névirapine fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Common French translation module (core metadata concept)


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Nevirapine (substance) est un(e) (attribut) Substance with cyclopropane structure (substance) true Inferred relationship Some
Nevirapine (substance) est un(e) (attribut) Reverse transcriptase inhibitor true Inferred relationship Some
Nevirapine (substance) est un(e) (attribut) Allergen class (substance) false Inferred relationship Some
Nevirapine (substance) est un(e) (attribut) Drug allergen (substance) false Inferred relationship Some
Nevirapine (substance) Has disposition (attribute) Reverse transcriptase inhibitor (disposition) true Inferred relationship Some
Nevirapine (substance) est un(e) (attribut) produit chimique catégorisé selon sa fonction false Inferred relationship Some
Nevirapine (substance) est un(e) (attribut) Heterocyclic compound true Inferred relationship Some
Nevirapine (substance) est un(e) (attribut) inhibiteur de la transférase false Inferred relationship Some

Inbound Relationships Type Active Source Characteristic Refinability Group
Lamivudine and nevirapine and stavudine only product a pour principe actif (attribut) True Nevirapine (substance) Inferred relationship Some 3
Lamivudine and nevirapine and zidovudine only product a pour principe actif (attribut) True Nevirapine (substance) Inferred relationship Some 2
Product containing only nevirapine (medicinal product) a pour principe actif (attribut) True Nevirapine (substance) Inferred relationship Some 1
Product containing only lamivudine and nevirapine and zidovudine in oral dose form (medicinal product form) a pour principe actif (attribut) True Nevirapine (substance) Inferred relationship Some 2
Product containing only lamivudine and nevirapine and stavudine in oral dose form (medicinal product form) a pour principe actif (attribut) True Nevirapine (substance) Inferred relationship Some 3
Product containing only nevirapine in oral dose form (medicinal product form) a pour principe actif (attribut) True Nevirapine (substance) Inferred relationship Some 1
Product containing precisely lamivudine 30 milligram and nevirapine 50 milligram and stavudine 6 milligram/1 each conventional release orodispersible tablet (clinical drug) Has basis of strength substance (attribute) True Nevirapine (substance) Inferred relationship Some 3
Product containing precisely lamivudine 30 milligram and nevirapine 50 milligram and stavudine 6 milligram/1 each conventional release orodispersible tablet (clinical drug) Has precise active ingredient True Nevirapine (substance) Inferred relationship Some 3
Lamivudine 150 mg and nevirapine 200 mg and stavudine 30 mg oral tablet Has basis of strength substance (attribute) True Nevirapine (substance) Inferred relationship Some 3
Lamivudine 150 mg and nevirapine 200 mg and stavudine 30 mg oral tablet Has precise active ingredient True Nevirapine (substance) Inferred relationship Some 3
Lamivudine and nevirapine and stavudine only product in oromucosal dose form a pour principe actif (attribut) True Nevirapine (substance) Inferred relationship Some 3
Product containing precisely lamivudine 60 milligram and nevirapine 100 milligram and stavudine 12 milligram/1 each conventional release orodispersible tablet (clinical drug) Has basis of strength substance (attribute) True Nevirapine (substance) Inferred relationship Some 3
Product containing precisely lamivudine 60 milligram and nevirapine 100 milligram and stavudine 12 milligram/1 each conventional release orodispersible tablet (clinical drug) Has precise active ingredient True Nevirapine (substance) Inferred relationship Some 3
Product containing precisely lamivudine 150 milligram and nevirapine 200 milligram and stavudine 40 milligram/1 each conventional release oral tablet (clinical drug) Has basis of strength substance (attribute) True Nevirapine (substance) Inferred relationship Some 3
Product containing precisely lamivudine 150 milligram and nevirapine 200 milligram and stavudine 40 milligram/1 each conventional release oral tablet (clinical drug) Has precise active ingredient True Nevirapine (substance) Inferred relationship Some 3
Product containing lamivudine and nevirapine and stavudine in oromucosal dose form (medicinal product form) a pour principe actif (attribut) True Nevirapine (substance) Inferred relationship Some 3
Nevirapine 50 mg prolonged-release oral tablet Has precise active ingredient True Nevirapine (substance) Inferred relationship Some 1
Nevirapine 50 mg prolonged-release oral tablet Has basis of strength substance (attribute) True Nevirapine (substance) Inferred relationship Some 1
Product containing precisely nevirapine 10 milligram/1 milliliter conventional release oral suspension (clinical drug) Has basis of strength substance (attribute) True Nevirapine (substance) Inferred relationship Some 1
Product containing precisely nevirapine 10 milligram/1 milliliter conventional release oral suspension (clinical drug) Has precise active ingredient True Nevirapine (substance) Inferred relationship Some 1
Product containing precisely nevirapine 100 milligram/1 each prolonged-release oral tablet (clinical drug) Has precise active ingredient True Nevirapine (substance) Inferred relationship Some 1
Product containing precisely nevirapine 100 milligram/1 each prolonged-release oral tablet (clinical drug) Has basis of strength substance (attribute) True Nevirapine (substance) Inferred relationship Some 1
Product containing precisely nevirapine 50 milligram/1 each tablet for conventional release oral suspension (clinical drug) Has precise active ingredient True Nevirapine (substance) Inferred relationship Some 1
Product containing precisely nevirapine 50 milligram/1 each tablet for conventional release oral suspension (clinical drug) Has basis of strength substance (attribute) True Nevirapine (substance) Inferred relationship Some 1
Product containing nevirapine (medicinal product) a pour principe actif (attribut) True Nevirapine (substance) Inferred relationship Some 1
Nevirapine 200 mg oral tablet a pour principe actif (attribut) False Nevirapine (substance) Inferred relationship Some
Nevirapine (as nevirapine hemihydrate) 10 mg/mL oral suspension a pour principe actif (attribut) False Nevirapine (substance) Inferred relationship Some
Product containing lamivudine and nevirapine and zidovudine (medicinal product) a pour principe actif (attribut) True Nevirapine (substance) Inferred relationship Some 2
Lamivudine 150 mg and nevirapine 200 mg and zidovudine 300 mg oral tablet a pour principe actif (attribut) False Nevirapine (substance) Inferred relationship Some
Product containing precisely lamivudine 60 milligram and nevirapine 100 milligram and stavudine 12 milligram/1 each conventional release orodispersible tablet (clinical drug) a pour principe actif (attribut) False Nevirapine (substance) Inferred relationship Some
Product containing precisely lamivudine 30 milligram and nevirapine 50 milligram and stavudine 6 milligram/1 each conventional release orodispersible tablet (clinical drug) a pour principe actif (attribut) False Nevirapine (substance) Inferred relationship Some
Product containing lamivudine and nevirapine and stavudine (medicinal product) a pour principe actif (attribut) True Nevirapine (substance) Inferred relationship Some 3
Lamivudine 150 mg and nevirapine 200 mg and stavudine 30 mg oral tablet a pour principe actif (attribut) False Nevirapine (substance) Inferred relationship Some
Product containing precisely lamivudine 150 milligram and nevirapine 200 milligram and stavudine 40 milligram/1 each conventional release oral tablet (clinical drug) a pour principe actif (attribut) False Nevirapine (substance) Inferred relationship Some
Nevirapine 400 mg prolonged-release oral tablet a pour principe actif (attribut) False Nevirapine (substance) Inferred relationship Some
Allergy to nevirapine Causative agent True Nevirapine (substance) Inferred relationship Some 1
Product containing nevirapine in oral dose form (medicinal product form) a pour principe actif (attribut) True Nevirapine (substance) Inferred relationship Some 1
Lamivudine- and nevirapine- and stavudine-containing product in oral dose form a pour principe actif (attribut) True Nevirapine (substance) Inferred relationship Some 3
Lamivudine- and nevirapine- and zidovudine-containing product in oral dose form a pour principe actif (attribut) True Nevirapine (substance) Inferred relationship Some 2
Nevirapine hemihydrate (substance) est un(e) (attribut) False Nevirapine (substance) Inferred relationship Some
Nevirapine 200 mg oral tablet a pour principe actif (attribut) False Nevirapine (substance) Inferred relationship Some 1
Nevirapine 200 mg oral tablet Has basis of strength substance (attribute) True Nevirapine (substance) Inferred relationship Some 1
Lamivudine 150 mg and nevirapine 200 mg and zidovudine 300 mg oral tablet a pour principe actif (attribut) False Nevirapine (substance) Inferred relationship Some 2
Lamivudine 150 mg and nevirapine 200 mg and zidovudine 300 mg oral tablet Has basis of strength substance (attribute) True Nevirapine (substance) Inferred relationship Some 2
Nevirapine 400 mg prolonged-release oral tablet Has basis of strength substance (attribute) True Nevirapine (substance) Inferred relationship Some 1
Nevirapine 400 mg prolonged-release oral tablet Has precise active ingredient True Nevirapine (substance) Inferred relationship Some 1
Nevirapine 200 mg oral tablet Has precise active ingredient True Nevirapine (substance) Inferred relationship Some 1
Lamivudine 150 mg and nevirapine 200 mg and zidovudine 300 mg oral tablet Has precise active ingredient True Nevirapine (substance) Inferred relationship Some 2
Nevirapine (as nevirapine hemihydrate) 10 mg/mL oral suspension Has basis of strength substance (attribute) False Nevirapine (substance) Inferred relationship Some 1
Nevirapine hemihydrate (substance) Is modification of (attribute) True Nevirapine (substance) Inferred relationship Some

This concept is not in any reference sets

Back to Start